Ontology highlight
ABSTRACT: Background
Alzheimer disease has no known cure. As existing pharmacologic interventions only modestly slow cognitive decline, there is a need for new treatments. Recent trials of repetitive transcranial magnetic stimulation (rTMS) have reported encouraging results for improving or stabilizing cognition in patients diagnosed with Alzheimer dementia. However, owing to small samples and lack of a well-controlled double-blind design, the results to date are inconclusive. This paper presents the protocol for a large placebo-controlled double-blind study designed with sufficient statistical rigor to measure the efficacy of rTMS treatment in patients with Alzheimer dementia.Objective
The objectives are to (1) recruit and enroll up to 200 eligible participants, (2) estimate the dif
SUBMITTER: Moussavi Z
PROVIDER: S-EPMC7822717 | biostudies-literature | 2021 Jan
REPOSITORIES: biostudies-literature